Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Expanded Access for CC-10004
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
- Status
- COMPLETED
- Phase
- PHASE3
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Effect of Evolocumab on Coronary Atherosclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
- Status
- COMPLETED
- Phase
- PHASE2
The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus
- Status
- UNKNOWN
- Phase
- PHASE2
Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta
- Status
- TERMINATED
- Phase
- PHASE3
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
- Status
- TERMINATED
- Phase
- PHASE4
Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Status
- RECRUITING
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase1 Study of VIB9600
- Status
- TERMINATED
- Phase
- PHASE1
Treatment Goals in Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- N/A
Reduced Dose-density of Denosumab for Unresectable GCTB
- Status
- TERMINATED
- Phase
- PHASE2